BBHC
MLAB icon

Brown Brothers Harriman & Co’s Mesa Laboratories MLAB Stock Holding History

Brown Brothers Harriman & Co’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-65
Closed -$9K – 1408
2022
Q3 		$9K Buy
65
+55
+550% +$10K ﹤0.01% 1174
2022
Q2 		$2K Sell
10
-35
-78% -$7.66K ﹤0.01% 1243
2022
Q1 		$11K Buy
+45
New +$12.2K ﹤0.01% 1015

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Brown Brothers Harriman & Co's MLAB Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Mesa Laboratories (MLAB) in Q4 2022, closing a stake of 65 shares — an estimated $9K sold.

Brown Brothers Harriman & Co first reported a position in MLAB in Q1 2022 and held it in 3 quarters. The position peaked at $11K in Q1 2022. 160 funds tracked by Wall St. Rank hold MLAB as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining Mesa Laboratories position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 65 Mesa Laboratories shares in Q4 2022, an estimated $9K.
  • Brown Brothers Harriman & Co first reported a position in Mesa Laboratories in Q1 2022 and held it in 3 quarters.
  • Brown Brothers Harriman & Co's Mesa Laboratories position peaked at $11K in Q1 2022.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.